Smart science to improve lives™
Open search Basket 0 View basket

Product Spotlight - Crodamol™ CCC Pharma

Crodamol™ CCC Pharma is a mild, non-irritating liquid emollient, ideal for sensitive site applications. The excipient can contribute to many benefits for various topical formulations.

Key benefits of Crodamol CCC Pharma:

Monograph compliant – Ph. Eur.
Enhances dermal permeation of many APIs
Non-irritating liquid emollient
Ideal for sensitive skin applications
Appealing sensory properties
Suitable for emulsions, ointments, gels and foams
Practically insoluble in water, miscible with alcohol and liquid paraffin.

Our extensive experience in skin science has led to the development of innovative ingredients that enhance the efficacy and patient perception of topical pharmaceuticals. Our topical excipients include drug delivery systems, skin penetration enhancers, solubilisers, emulsifiers and emollients.

Crodamol CCC pharma

Crodamol™ CCC pharma

Cocoyl caprylocaprate is used in topical formulations. It is a non-irritating liquid ideal for sensitive site applications. The excipient can contribute to many benefits for various topical systems...
Add to favourites Add product to favourites

PRODUCT USE CASE STUDY

Emugel formulation: "We need a light-feeling gelled emulsion to offer rapid pain relief"

Explore recent blogs:

headshot of Dennis Christenson

New Research Professor MSO in Vaccine Adjuvants at Statens Serum Institut Copenhagen, Denmark

PRESS RELEASE: Croda Pharma is happy to announce that Dennis Christensen, PhD, Head of Global Research and Development for Vaccine Adjuvant Systems, has been appointed as a part-time Research...
Solubilisers and Emulsifiers

Surfactants in biopharmaceutical development

Discover insights from our industry experts
man in a lab looking at results

Croda Pharma launches a new bioprocessing solution for shear stress in mammalian cell culture

Croda Pharma has announced the launch of Super Refined™ Poloxamer 188, an innovative bioprocessing solution developed to meet the increasing demands of biopharmaceutical development.